Bertrand Delafaye - McDermott Will & Emery

Overview


Bertrand Delafaye advises strategic clients and investment funds on complex transactions, including private and public M&A, leveraged buyouts and joint venture transactions. Bertrand has also extensive experience in equity and equity-linked securities offerings, representing issuers, underwriters, and shareholders and more generally in securities and corporate law and corporate governance issues faced by publicly listed companies. He also has significant experience in the international arena, including cross-border M&A transactions.

Bertrand regularly handles pre- and post-closing disputes in the context of M&A transactions, and regularly advises on disputes among shareholders or joint venture partners.

Results


  • Advised the shareholders of Limflow in the sale of Limflow to Inari Medical International Inc
  • Advised Biocorp Productions (Euronext Growth) in the public tender offer of Novo Nordisk over its securities
  • Advised Pherecydes Pharma (Euronext Growth) in its merger with Erytech Pharma (Euronext and Nasdaq) to form Phaxiam Therapeutics

Show More

Recognitions


  • The Legal 500 EMEA, Recommended, 2022-2024
  • The Best Lawyers in France, 2024

Credentials


Education
University of Paris I Panthéon-Sorbonne, LLM (DEA), Business Law, 1997
University of Paris II Panthéon-Assas, LLM (DESS), Insurance Law, 1996

Admissions
Paris

Languages
English
French